Literature DB >> 33925632

Theranostic Advances in Breast Cancer in Nuclear Medicine.

Nasim Vahidfar1, Ayuob Aghanejad2, Hojjat Ahmadzadehfar3, Saeed Farzanehfar1, Elisabeth Eppard4,5.   

Abstract

The implication of 'theranostic' refers to targeting an identical receptor for diagnostic and therapeutic purposes, by the same radioligand, simultaneously or separately. In regard to extensive efforts, many considerable theranostic tracers have been developed in recent years. Emerging evidence strongly demonstrates the tendency of nuclear medicine towards therapies based on a diagnosis. This review is focused on the examples of targeted radiopharmaceuticals for the imaging and therapy of breast cancer.

Entities:  

Keywords:  imaging; radiopharmaceutical; theranostic; therapy

Year:  2021        PMID： 33925632     DOI： 10.3390/ijms22094597

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN： 1422-0067            Impact factor:   5.923


  73 in total

1.  Confusion in the nomenclature of ketogenic diets blurs evidence.

Authors:  Pierpaolo Trimboli; Marco Castellana; Diego Bellido; Felipe F Casanueva
Journal:  Rev Endocr Metab Disord       Date:  2020-03       Impact factor: 6.514

2.  Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue.

Authors:  T J McDonald; H Jörnvall; G Nilsson; M Vagne; M Ghatei; S R Bloom; V Mutt
Journal:  Biochem Biophys Res Commun       Date:  1979-09-12       Impact factor: 3.575

Review 3.  Breast cancer.

Authors:  Nadia Harbeck; Frédérique Penault-Llorca; Javier Cortes; Michael Gnant; Nehmat Houssami; Philip Poortmans; Kathryn Ruddy; Janice Tsang; Fatima Cardoso
Journal:  Nat Rev Dis Primers       Date:  2019-09-23       Impact factor: 52.329

4.  Prognostic factors in 1,038 women with metastatic breast cancer.

Authors:  R Largillier; J-M Ferrero; J Doyen; J Barriere; M Namer; V Mari; A Courdi; J M Hannoun-Levi; F Ettore; I Birtwisle-Peyrottes; C Balu-Maestro; P Y Marcy; I Raoust; M Lallement; E Chamorey
Journal:  Ann Oncol       Date:  2008-07-17       Impact factor: 32.976

5.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

6.  The use of the Gail model, body mass index and SNPs to predict breast cancer among women with abnormal (BI-RADS 4) mammograms.

Authors:  Anne Marie McCarthy; Brad Keller; Despina Kontos; Leigh Boghossian; Erin McGuire; Mirar Bristol; Jinbo Chen; Susan Domchek; Katrina Armstrong
Journal:  Breast Cancer Res       Date:  2015-01-08       Impact factor: 6.466

7.  Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA5m chelators.

Authors:  Euy Sung Moon; Filipe Elvas; Gwendolyn Vliegen; Stef De Lombaerde; Christel Vangestel; Sven De Bruycker; An Bracke; Elisabeth Eppard; Lukas Greifenstein; Benedikt Klasen; Vasko Kramer; Steven Staelens; Ingrid De Meester; Pieter Van der Veken; Frank Rösch
Journal:  EJNMMI Radiopharm Chem       Date:  2020-07-29

Review 8.  The role of general nuclear medicine in breast cancer.

Authors:  Lacey R Greene; Deborah Wilkinson
Journal:  J Med Radiat Sci       Date:  2015-02-12

9.  GRPR-targeted Protein Contrast Agents for Molecular Imaging of Receptor Expression in Cancers by MRI.

Authors:  Fan Pu; Jingjuan Qiao; Shenghui Xue; Hua Yang; Anvi Patel; Lixia Wei; Khan Hekmatyar; Mani Salarian; Hans E Grossniklaus; Zhi-Ren Liu; Jenny J Yang
Journal:  Sci Rep       Date:  2015-11-18       Impact factor: 4.379

10.  Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples.

Authors:  Clément Morgat; Romain Schollhammer; Gaétan Macgrogan; Nicole Barthe; Valérie Vélasco; Delphine Vimont; Anne-Laure Cazeau; Philippe Fernandez; Elif Hindié
Journal:  PLoS One       Date:  2019-01-15       Impact factor: 3.240
View more
  4 in total

1.  [Oncological theranostics in nuclear medicine].

Authors:  Christina Laschinsky; Ken Herrmann; Wolfgang Fendler; Michael Nader; Harald Lahner; Boris Hadaschik; Patrick Sandach
Journal:  Radiologie (Heidelb)       Date:  2022-10

Review 2.  A Review of Nuclear Medicine Approaches in the Diagnosis and the Treatment of Gynecological Malignancies.

Authors:  Nasim Vahidfar; Saeed Farzanefar; Hojjat Ahmadzadehfar; Eóin N Molloy; Elisabeth Eppard
Journal:  Cancers (Basel)       Date:  2022-03-31       Impact factor: 6.639

Review 3.  Diagnostic Value of Radiolabelled Somatostatin Analogues for Neuroendocrine Tumour Diagnosis: The Benefits and Drawbacks of [64Cu]Cu-DOTA-TOC.

Authors:  Nasim Vahidfar; Saeed Farzanehfar; Mehrshad Abbasi; Siroos Mirzaei; Ebrahim S Delpassand; Farzad Abbaspour; Yalda Salehi; Hans Jürgen Biersack; Hojjat Ahmadzadehfar
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

4.  Implementation of a Design of Experiments to Improve Periplasmic Yield of Functional ScFv Antibodies in a Phage Display Platform.

Authors:  Marjan Abri Aghdam; Mohammad Reza Tohidkia; Elham Ghamghami; Asadollah Ahmadikhah; Morteza Khanmahamadi; Behzad Baradaran; Ahad Mokhtarzadeh
Journal:  Adv Pharm Bull       Date:  2021-07-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.